Compare $VIR vs $ZBIO | Chartloom

Compare

$VIR vs $ZBIO

Vir Biotechnology Inc · Zenas Biopharma Inc

VIR

Vir Biotechnology Inc

ZBIO

Zenas Biopharma Inc

Compare $VIR vs $ZBIO

Comparing Vir Biotechnology Inc and Zenas Biopharma Inc

VIRVir Biotechnology Inc

ZBIOZenas Biopharma Inc

VIRVir Biotechnology Inc

Market cap

$1.97B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

36.09x

Rev growth (TTM)

1496.1%

YTD performance

97.0%

52W performance

93.4%

FCF yield

-10.3%

ZBIOZenas Biopharma Inc

Market cap

$1.72B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-93.3%

YTD performance

-21.0%

52W performance

5.3%

FCF yield

-16.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

VIR

ZBIO

Detailed metrics comparison

VIR

Vir Biotechnology Inc

ZBIO

Zenas Biopharma Inc

Market Cap

VIR$1.97B

ZBIO$1.72B

Enterprise Value

VIR$1.69B

ZBIO$1.91B

Price

VIR$11.70

ZBIO$27.26

P/E Ratio

VIRN/A

ZBION/A

P/S Ratio

VIR6.51x

ZBIO1,720.92x

EV/Sales

VIR5.59x

ZBIO1,913.10x

EV/EBITDA

VIR1.92x

ZBIO0.00x

P/B Ratio

VIR1.92x

ZBIO7.47x

P/FCF Ratio

VIRN/A

ZBION/A

EV/FCF

VIR-8.32x

ZBIO-6.57x

PEG Ratio

VIRN/A

ZBION/A

Forward P/E (NTM)

VIRN/A

ZBION/A

Forward P/S (NTM)

VIR36.09x

ZBION/A

Revenue (TTM)

VIR$303M

ZBIO$1M

Revenue Growth (YoY)

VIR1496.1%

ZBIO-93.3%

Forward Rev Growth

VIR-58.9%

ZBIO5296.9%

Gross Margin (TTM)

VIR100.0%

ZBIO0.0%

Operating Margin (TTM)

VIR0.0%

ZBIO0.0%

EBITDA Margin (TTM)

VIR-45.9%

ZBIO-27387.0%

Net Margin (TTM)

VIR-41.5%

ZBIO-48438.4%

FCF Margin (TTM)

VIR-67.1%

ZBIO-29097.4%

Net Income (TTM)

VIR$-126M

ZBIO$-484M

FCF (TTM)

VIR$-204M

ZBIO$-291M

EPS (TTM)

VIR-$0.75

ZBIO-$7.67

ROE (TTM)

VIR-1486.0%

ZBIO-18968.0%

ROA (TTM)

VIR-1168.0%

ZBIO-8991.0%

ROIC (TTM)

VIR-1486.0%

ZBIO-10131.0%

Cash

VIR$279M

ZBIO$197M

Debt

VIR$0

ZBIO$389M

Net Cash/Debt

VIR$279M

ZBIO$-192M

Current Ratio (TTM)

VIR6.04x

ZBIO9.93x

Quick Ratio (TTM)

VIR5.69x

ZBIO9.77x

Debt/Equity (TTM)

VIR0.00x

ZBIO1.57x

Debt/Assets (TTM)

VIR0.0%

ZBIO0.0%

Interest Coverage (TTM)

VIRN/A

ZBION/A

Net Debt/EBITDA (TTM)

VIR0.00x

ZBIO0.00x

Beta

VIR1.77

ZBIO0.70

52W Performance

VIR93.4%

ZBIO5.3%

YTD Performance

VIR97.0%

ZBIO-21.0%

% from 52W High

VIR-2.6%

ZBIO-38.9%

% from 52W Low

VIR143.0%

ZBIO101.9%

Asset Turnover (TTM)

VIR0.28x

ZBIO0.00x

FCF Yield (TTM)

VIR-10.3%

ZBIO-16.9%

Earnings Yield (TTM)

VIR-6.4%

ZBIO-28.1%

Dividend Yield (TTM)

VIRN/A

ZBION/A

Rule of 40

VIR1,428.9

ZBIO-29,190.7

EV/GP/RG

VIRN/A

ZBION/A

Ticker research

View VIR research View ZBIO research

Metric	VIR Vir Biotechnology Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$1.97B	$1.72B
Enterprise Value	$1.69B	$1.91B
Price	$11.70	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	6.51x	1,720.92x
EV/Sales	5.59x	1,913.10x
EV/EBITDA	1.92x	0.00x
P/B Ratio	1.92x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.32x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	36.09x	N/A
Revenue & Growth
Revenue (TTM)	$303M	$1M
Revenue Growth (YoY)	1496.1%	-93.3%
Forward Rev Growth	-58.9%	5296.9%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.9%	-27387.0%
Net Margin (TTM)	-41.5%	-48438.4%
FCF Margin (TTM)	-67.1%	-29097.4%
Net Income (TTM)	$-126M	$-484M
FCF (TTM)	$-204M	$-291M
EPS (TTM)	-$0.75	-$7.67
ROE (TTM)	-1486.0%	-18968.0%
ROA (TTM)	-1168.0%	-8991.0%
ROIC (TTM)	-1486.0%	-10131.0%
Financial Health
Cash	$279M	$197M
Debt	$0	$389M
Net Cash/Debt	$279M	$-192M
Current Ratio (TTM)	6.04x	9.93x
Quick Ratio (TTM)	5.69x	9.77x
Debt/Equity (TTM)	0.00x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.77	0.70
52W Performance	93.4%	5.3%
YTD Performance	97.0%	-21.0%
% from 52W High	-2.6%	-38.9%
% from 52W Low	143.0%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-10.3%	-16.9%
Earnings Yield (TTM)	-6.4%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,428.9	-29,190.7
EV/GP/RG	N/A	N/A
Ticker research	View VIR research	View ZBIO research

Valuation

P/S Ratio

VIR

6.51x

ZBIO

1,720.92x

EV/FCF

VIR

-8.32x

ZBIO

-6.57x

Growth & revenue

Revenue Growth TTM

VIR

1496.1%

ZBIO

-93.3%

Forward Revenue Growth

ZBIO

5296.9%

VIR

-58.9%

Profitability & performance

Gross Margin

VIR

100.0%

ZBIO

0.0%

ROE

VIR

-1486.0%

ZBIO

-18968.0%

FCF Yield %

VIR

-10.3%

ZBIO

-16.9%

52-Week Performance

VIR

93.4%

ZBIO

5.3%

Detailed metrics comparison

VIR

Vir Biotechnology Inc

ZBIO

Zenas Biopharma Inc

Market Cap

VIR$1.97B

ZBIO$1.72B

Enterprise Value

VIR$1.69B

ZBIO$1.91B

Price

VIR$11.70

ZBIO$27.26

P/E Ratio

VIRN/A

ZBION/A

P/S Ratio

VIR6.51x

ZBIO1,720.92x

EV/Sales

VIR5.59x

ZBIO1,913.10x

EV/EBITDA

VIR1.92x

ZBIO0.00x

P/B Ratio

VIR1.92x

ZBIO7.47x

P/FCF Ratio

VIRN/A

ZBION/A

EV/FCF

VIR-8.32x

ZBIO-6.57x

PEG Ratio

VIRN/A

ZBION/A

Forward P/E (NTM)

VIRN/A

ZBION/A

Forward P/S (NTM)

VIR36.09x

ZBION/A

Revenue (TTM)

VIR$303M

ZBIO$1M

Revenue Growth (YoY)

VIR1496.1%

ZBIO-93.3%

Forward Rev Growth

VIR-58.9%

ZBIO5296.9%

Gross Margin (TTM)

VIR100.0%

ZBIO0.0%

Operating Margin (TTM)

VIR0.0%

ZBIO0.0%

EBITDA Margin (TTM)

VIR-45.9%

ZBIO-27387.0%

Net Margin (TTM)

VIR-41.5%

ZBIO-48438.4%

FCF Margin (TTM)

VIR-67.1%

ZBIO-29097.4%

Net Income (TTM)

VIR$-126M

ZBIO$-484M

FCF (TTM)

VIR$-204M

ZBIO$-291M

EPS (TTM)

VIR-$0.75

ZBIO-$7.67

ROE (TTM)

VIR-1486.0%

ZBIO-18968.0%

ROA (TTM)

VIR-1168.0%

ZBIO-8991.0%

ROIC (TTM)

VIR-1486.0%

ZBIO-10131.0%

Cash

VIR$279M

ZBIO$197M

Debt

VIR$0

ZBIO$389M

Net Cash/Debt

VIR$279M

ZBIO$-192M

Current Ratio (TTM)

VIR6.04x

ZBIO9.93x

Quick Ratio (TTM)

VIR5.69x

ZBIO9.77x

Debt/Equity (TTM)

VIR0.00x

ZBIO1.57x

Debt/Assets (TTM)

VIR0.0%

ZBIO0.0%

Interest Coverage (TTM)

VIRN/A

ZBION/A

Net Debt/EBITDA (TTM)

VIR0.00x

ZBIO0.00x

Beta

VIR1.77

ZBIO0.70

52W Performance

VIR93.4%

ZBIO5.3%

YTD Performance

VIR97.0%

ZBIO-21.0%

% from 52W High

VIR-2.6%

ZBIO-38.9%

% from 52W Low

VIR143.0%

ZBIO101.9%

Asset Turnover (TTM)

VIR0.28x

ZBIO0.00x

FCF Yield (TTM)

VIR-10.3%

ZBIO-16.9%

Earnings Yield (TTM)

VIR-6.4%

ZBIO-28.1%

Dividend Yield (TTM)

VIRN/A

ZBION/A

Rule of 40

VIR1,428.9

ZBIO-29,190.7

EV/GP/RG

VIRN/A

ZBION/A

Ticker research

View VIR research View ZBIO research

Metric	VIR Vir Biotechnology Inc	ZBIO Zenas Biopharma Inc
Market & Valuation
Market Cap	$1.97B	$1.72B
Enterprise Value	$1.69B	$1.91B
Price	$11.70	$27.26
P/E Ratio	N/A	N/A
P/S Ratio	6.51x	1,720.92x
EV/Sales	5.59x	1,913.10x
EV/EBITDA	1.92x	0.00x
P/B Ratio	1.92x	7.47x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.32x	-6.57x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	36.09x	N/A
Revenue & Growth
Revenue (TTM)	$303M	$1M
Revenue Growth (YoY)	1496.1%	-93.3%
Forward Rev Growth	-58.9%	5296.9%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-45.9%	-27387.0%
Net Margin (TTM)	-41.5%	-48438.4%
FCF Margin (TTM)	-67.1%	-29097.4%
Net Income (TTM)	$-126M	$-484M
FCF (TTM)	$-204M	$-291M
EPS (TTM)	-$0.75	-$7.67
ROE (TTM)	-1486.0%	-18968.0%
ROA (TTM)	-1168.0%	-8991.0%
ROIC (TTM)	-1486.0%	-10131.0%
Financial Health
Cash	$279M	$197M
Debt	$0	$389M
Net Cash/Debt	$279M	$-192M
Current Ratio (TTM)	6.04x	9.93x
Quick Ratio (TTM)	5.69x	9.77x
Debt/Equity (TTM)	0.00x	1.57x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.77	0.70
52W Performance	93.4%	5.3%
YTD Performance	97.0%	-21.0%
% from 52W High	-2.6%	-38.9%
% from 52W Low	143.0%	101.9%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-10.3%	-16.9%
Earnings Yield (TTM)	-6.4%	-28.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	1,428.9	-29,190.7
EV/GP/RG	N/A	N/A
Ticker research	View VIR research	View ZBIO research